1. MicroRNAs as novel biomarkers for the diagnosis and treatment of pediatric diseases
    Hwal Rim Jeong et al, 2024, Clinical and Experimental Pediatrics CrossRef
  2. Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 Axis
    Xue Wang et al, 2021, Inflammation CrossRef

  3. Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting p27 Kip1


    Yiyu Qin et al, 2020, OncoTargets and Therapy CrossRef
  4. Crucial transcripts predict response to initial immunoglobulin treatment in acute Kawasaki disease
    Zhimin Geng et al, 2020, Scientific Reports CrossRef
  5. Epigenetics in Kawasaki Disease
    Kaushal Sharma et al, 2021, Frontiers in Pediatrics CrossRef
  6. A review on the role of miR-671 in human disorders
    Soudeh Ghafouri-Fard et al, 2022, Frontiers in Molecular Biosciences CrossRef
  7. Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients
    Bruna De Felice et al, 2020, Scientific Reports CrossRef
  8. Association Between rs12037447, rs146732504, rs151078858, rs55723436, and rs6094136 Polymorphisms and Kawasaki Disease in the Population of Polish Children
    Piotr Buda et al, 2021, Frontiers in Pediatrics CrossRef
  9. Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease
    Yuqing Yan et al, 2024, Metabolic Brain Disease CrossRef
  10. Current State of Precision Medicine in Primary Systemic Vasculitides
    Erkan Demirkaya et al, 2019, Frontiers in Immunology CrossRef
  11. MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring
    Yiyi Xiong et al, 2022, Frontiers in Immunology CrossRef
  12. Research progress on the role and mechanism of miR-671 in bone metabolism and bone-related diseases
    Shaotai Wang et al, 2023, Frontiers in Oncology CrossRef